pseudomonas

Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.
(redirected from Pseudomonas aeruginosa)

pseu·do·mo·nas

 (so͞o′də-mō′nəs, so͞o-dŏm′ə-nəs)
n. pl. pseu·do·mon·a·des (-mŏn′ə-dēz′)
Any of various gram-negative, rod-shaped, mostly aerobic flagellated bacteria of the genus Pseudomonas, commonly found in soil, water, and decaying matter, and including some plant and animal pathogens.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

pseudomonas

(sjuːˈdɒmənəs)
n, pl pseudomonades (ˌsjuːdəʊˈmɒnədiːz)
(Microbiology) any of a genus of rodlike Gram-negative bacteria that live in soil and decomposing organic matter: many species are pathogenic to plants and a few are pathogenic to man
[C20: from New Latin, from pseudo- + Greek monas unit]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Pseudomonas - type genus of the family Pseudomonodaceae
bacteria genus - a genus of bacteria
Pseudomonas pyocanea - a species of aerobic bacteria
family Pseudomonodaceae, Pseudomonodaceae - rod-shaped Gram-negative bacteria; include important plant and animal pathogens
pseudomonad - bacteria usually producing greenish fluorescent water-soluble pigment; some pathogenic for plants and animals
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in
References in periodicals archive
According to SFA, Pseudomonas aeruginosa can be found in faeces, soil, water and sewage.
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
Effect of pyocyanin extracted from Pseudomonas aeruginosa on other pathogenic bacteria in vitro.
Unfortunately, Pseudomonas aeruginosa demonstrates resistance to multiple antibiotics, thereby jeopardizing the selection of appropriate treatment.
Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: Case report and review of the literature.
The company's lead clinical stage product candidates, AB-SA01 and AB-PA01, target multidrug-resistant Staphylococcus aureus and Pseudomonas aeruginosa, which are included on the WHO's 2017 Priority Pathogens List.
Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-[beta]-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.